Anteilseigner
Driehaus Capital Management LLC (6,71 %) Point72 Asset Management LP (6,35 %) BlackRock Fund Advisors (6,24 %) EcoR1 Capital, LLC (5,33 %) Fidelity Management & Research Co. LLC (5,02 %) T. Rowe Price Associates, Inc. (Investment Management) (4,80 %) The Vanguard Group, Inc. (4,44 %) SSgA Funds Management, Inc. (4,18 %) Paradigm BioCapital Advisors LP (4,01 %) Wellington Management Co. LLP (3,81 %) Jennison Associates LLC (3,62 %) T. Rowe Price Investment Management, Inc. (3,41 %) Janus Henderson Investors US LLC (2,50 %) First Light Asset Management LLC (2,17 %) Perceptive Advisors LLC (1,89 %) Geode Capital Management LLC (1,80 %) Invus Public Equities Advisors LLC (1,78 %) OrbiMed Advisors Private Equity (1,78 %) Bain Capital Life Sciences LP (1,64 %) Scott R. Struthers (1,49 %)
Kontakt
CRINETICS PHARMACEUTICALS INC